Upadacitinib and Cardiovascular Safety Across Immune-Mediated Inflammatory Diseases: Reassurance Without Certainty

Scritto il 05/10/2026
da Michael Garshick

No abstract

J Cardiovasc Pharmacol. 2026 Oct 5. doi: 10.1097/FJC.0000000000001883. Online ahead of print.

NO ABSTRACT

PMID:42832635 | DOI:10.1097/FJC.0000000000001883